Announcement on Unblinding Results of the Phase III Clinical Trial of Company's Class 1 New Drug LH-1801 Tablets Combined with Metformin
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference: View Attachment
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference: View Attachment
